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ABSTRACT
Erectile dysfunction (ED) is considered as an early sign of endothelial
dysfunction and cardiovascular disease. The present review gives an overview of
the physiological factors involved in the regulation of penile vasculature with
special regard to the role of the vascular endothelium. Sympathetic nerves maintain
flaccidity and mediate detumescence through the release of the vasoconstrictor
noradrenaline that down-regulates its own release and that of nitric oxide (NO).
The sympathetic cotransmitter neuropeptide Y (NPY) enhances noradrenergic
vasoconstriction and also elicits non-NO endothelium-dependent relaxations. α1-
adrenoceptor-mediated vasoconstriction involves Ca2+ influx through L-type and
receptor-operated (ROC) Ca2+ channels, as well as Ca2+ sensitization mechanisms
mediated by protein kinase C (PKC), tyrosine kinases (TKs) and Rho kinase (RhoK)
in penile small arteries. Rho kinase (RhoK) can regulate Ca2+ entry in addition to
its role in Ca2+ sensitization. Vasodilatation of penile arteries and large veins during
erection is mediated by neurally-released NO and the subsequent increased arterial
inflow and shear stress activates endothelial NO production through Akt-
phosphorylation of endothelial NO synthase (eNOS). cyclic guanonin 3´-
monophosphate (cGMP)-stimulated K+ efflux through Ca2+-activated (KCa) and
voltage-dependent Ca2+ (Kv) channels is involved in the NO relaxant responses of
penile arteries and veins, respectively. Phoshodiesterase type 5 (PDE5) inhibitors
are potent vasodilators of penile arteries and increase the effects of basally released
endothelial NO. Endothelium-dependent relaxations of penile small arteries include
an endothelium-derived hyperpolarizing factor (EDHF)-type response which is
* e mail: agarsac@farm.ucm.es
An. R. Acad. Nac. Farm., 2007, 73 (4): 963-985
Revisión
DOLORES PRIETO Y ALBINO GARCÍA SACRISTÁN ANAL. REAL ACAD. NAC. FARM.
964
impaired in diabetes and hypertension associated ED. The changes in structure
and function in the penile vasculature in cardiovascular risk situations leading to
ED remain to be elucidated.
Key words: Penile arteries, nerves, endothelial cells, nitric oxide, vasculogenic
erectile dysfunction.
RESUMEN
Fisiología de los vasos sanguíneos peneanos: endotelio y disfunción eréctil
Se considera la disfunción eréctil (DE) una manifestación temprana de
disfunción endotelial y enfermedad cardiovascular. En el presente trabajo se
resumen los factores fisiológicos implicados en la regulación de los vasos
sanguíneos peneanos, con especial referencia al papel del endotelio vascular.
Los nervios simpáticos mantienen la flacidez y median la detumescencia a través
de la liberación de noradrenalina que regula su propia liberación y la de óxido
nítrico (NO). El cotransmisor simpático neuropéptido Y (NPY) potencia la
vasoconstricción noradrenérgica y también produce relajación endotelial no
mediada por NO. La vasoconstricción α1-adrenérgica está mediada por la entrada
de Ca2+ a través de canales tipo L y canales operados por receptor, así como
también mecanismos de sensibilización al Ca2+ mediados por la proteína kinasa C
(PKC), tirosina kinasas y la kinasa Rho (RhoK). La RhoK puede regular la entrada
de Ca2+ además de su papel en la sensibilización al Ca2+. La vasodilatación de las
arterias y venas grandes durante la erección está mediada por NO de origen
nervioso y el posterior incremento del influjo de sangre arterial y shear-stress
activa la producción de NO endotelial a través de la fosforilación Akt de la enzima
NOS endotelial (eNOS). El eflujo de K+ estimulado por el guanosín monofosfato
cíclico (GMPc) a través de canales de K+ activados por Ca2+ (KCa) y por voltaje (Kv)
está implicado en el efecto relajante del NO en arterias y venas peneanas. Los
inhibidores de la fosfodiesterasa tipo 5 (PDE5) son potentes vasodilatadores de las
arterias peneanas que incrementan los efectos del NO endotelial liberado
basalmente. Las respuestas relajantes dependientes del endotelio incluyen una
respuesta de tipo factor hiperolarizante derivado del endotelio (EDHF) en las arterias
peneanas pequeñas que está alterada en la DE asociada a la diabetes y la
hipertensión. Los cambios en estructura y función de los vasos sanguíneos
penenanos en situaciones de riesgo cardiovascular que ocasionan DE están todavía
por clarificar.
Palabras clave: Arterias peneanas, nervios, célula endotelial, óxido nítrico,
disfunción eréctil vasculogénica.
VOL. 73 (4), 963-985, 2007 PHISIOLOGY OF PENILE VASCULATURE...
965
INTRODUCTION
Erectile dysfunction (ED), defined as the consistent inability to
achieve and maintain a penile erection sufficient for adequate sexual
performance (1), is a predominantly vascular disease with a high
prevalence in patients with vascular disorders such as diabetes,
aging, hypercholesterolemia, hypertension, sedentary life style and
cigarette smoking (2, 3). Loss of endothelium integrity and
subsequent endothelial dysfunction during the latter pathological
conditions plays an essential role in the pathogenesis of ED.
Therefore, ED is considered as an early manifestation of systemic
endothelial dysfunction and cardiovascular disease (4).
The nitric oxide (NO) pathway is of critical importance in the
physiology of penile erection and also in the pathophysiology and
pharmacological management of ED (4-6). The constitutive
endothelial NO synthase (eNOS) and neuronal NO synthase (nNOS)
isoforms are tightly regulated and produce relevant levels of NO in
endothelial cells and autonomic nerve endings of the penis (4). Penile
erection occurs when NO released from nerve terminals and
endothelium upon sexual stimulation decreases vascular resistance
and increases blood flow through cavernous and helicine arteries.
This allows the filling of the sinoids, the rise in intracavernosal
pressure (ICP) and the restriction of venous outflow by compression
of subtunical veins against the tunica albuginea with entrapment of
pressurized blood in the corpora cavernosa, which is referred to as
veno-occlusive mechanism (5, 7, 8). ED can be considered as a three-
fold process where arterial insufficiency is followed by inability to
obtain tumescence due to deffective filling of the corpum
cavernosum (CC) and faulty veno-occlusion (9).
Penile erection and flaccidity are ultimately regulated by the
relaxation and contraction, respectively, of erectile smooth muscle,
and a metabolic imbalance between contractile and relaxant factors
in the CC, penile arterties and veins is one of the main causes of
organic ED. The present review summarizes the research work
carried out by our group for more than a decade on the mechanims
underlying the contractile/relaxant processes of the penile
vasculature, with special regard to the role of the vascular
endothelium in the phsyiology of erection, in the pathophsyiology of
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ED and in the action of vasoactive drugs currently used in the
therapy of ED.
REGULATION OF PENILE VASOCONSTRICTION
AND FLACCIDITY
Sympathetic nerves
Sympathetic adrenergic nerves are responsible for the detu-
mescence of the erect penis and also contribute to the maintenance
of penile flaccidity through the tonic release of noradrenaline (10).
Noradrenaline induces contraction of CC smooth muscle and arterial
vasoconstriction, which leads to the reduction of arterial inflow
and to the collapse of the lacunar spaces, respectively, allowing
decompression of subtunical venules and venous drainage of the
corpora (5, 7, 11). Neural-released noradrenaline evokes vasocons-
triction through a mixed population of postjunctional α1- and α2-
adrenoceptors in the isolated cavernous artery (12), and only through
α1-adrenoceptors in horse penile resistance arteries (13). Noradre-
naline down-regulates its own release from adrenergic nerves acting
on inhibitory prejunctional α2-adrenoceptors in intracavernous
arteries (13).
Besides the mechanical restriction of the venous outflow during
the veno-occlusive mechanism, there is evidence for an active
regulation of penile veins and adrenergic stimuli induce veno-
constriction through and heterogenous population of α1- and α2-
postjunctional adrenoceptors in both circumflex (14) and deep dorsal
veins (15). In the latter, noradrenergic nerve terminals penetrate
deep in the smooth muscle effector layer which represents a
mechanism to respond faster and more extensively to the
vasoconstrictor nerve activity.
In addition to its classical vasoconstrictor role, adrenergic
transmitters can also induce vasodilatation in penile arteries through
β-adrenoceptors, which is related to the increased plasma adrenaline
levels during erection. By acting on β2-adrenoceptors (7, 13),
adrenaline would further increase arterial inflow to the penis in
connection with the increased metabolism and physical activity
during sexual intercourse.
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Activation of sympathetic nerves still has antierectile effects under
conditions of α-adrenoceptor blockade suggesting that neuro-
transmitters other than noradrenaline may contribute to the
vasoconstrictor sympathetic activity in the penis (10). Neuro-
peptide Y (NPY), a 36-aminoacid peptide usually colocalized with
noradrenaline in sympathetic perivascular nerves, is widely
distributed in penile erectile tissues with a particularly high density
around helicine arteries (16, 17). Although NPY was initially
suggested to have a role in detumescence (10), earlier in vitro studies
on the contractile effects of the peptide on erectile tissue rendered
controversial results (16), and in vivo investigations showed that
intracavernous injection of NPY increased intracavernous pressure in
rabbits (18). We have recently provided an explanation for this
controversy between the rich presence of NPY-containing nerves in
the penis and the lack of clear antierectile/vasconstrictor effects of the
peptide (17). Thus, NPY has a dual facilitatory/inhibitory modulatory
role on the noradrenergic vasoconstriction of horse penile resistance
arteries, the ability to enhance and decrease noradrenaline-induced
contractions being achieved through a heterogenous population of
NPY receptors. Both Y1 and Y2 postsynaptic receptors are involved in
the NPY-induced enhancement of noradrenaline contractions, and
presynaptic inhibitory Y2 receptors limit noradrenaline release form
nerve terminals. The Y1 receptor is a G-protein-coupled receptor that
usually enhances other constrictors responses in small arteries by
depolarizing arterial smooth muscle and by inhibiting cAMP-
mediated relaxations (19, 20). Under conditions of Y1 and Y2 receptor
blockade, NPY can also induce NO-independent relaxations in penile
resistance arteries through atypical receptors located at the
endothelium, which could account for the in vivo proerectogenic
effects reported for the peptide (18).
Local factors regulating penile vasoconstriction
Several contractile prostanoids are locally synthesized and
metabolized in penile erectile tissues (21). Whereas in CC basal pro-
stanoid production is involved in the maintenance of the myogenic
spontanous tone consisting of phasic and tonic contractions (21), in
penile resistance arteries arterial spontaneous tone is modulated by
DOLORES PRIETO Y ALBINO GARCÍA SACRISTÁN ANAL. REAL ACAD. NAC. FARM.
968
basal-released relaxant prostanoids (22). On the other hand, agonist-
induced endothelial stimulation of both human and rabbit CC and
horse deep dorsal penile veins evokes the release of contractile
prostanoids (23, 24). The main receptor involved in the contractile
effect of prostanoids in the human penis belongs to the PGH2/TP
type (25, 26).
Angiotensin II (AII) is locally formed in the endothelium and
smooth muscle of the CC, where its contractile effects are mediated
by muscular AT-1 receptors (27-29). Since AII levels are increased in
the cavernous blood during detumescence (29), this peptide has been
suggested to be involved in the initiation of detumescence as a
consequence of enhanced sympathetic activity. However, the
functional role of AII in penile arteries and veins remains to be
established.
Endothelins (ETs) are potent vasoconstrictor peptides synthesized
by endothelial cells that induce both contraction and ETB-mediated
relaxation of erectile tissues (30, 31). ETA and ETB receptors subtypes
are located at penile smooth muscle and nerves, respectively (30),
and infusion of ET-1 and ET-3 in the rat increases intracavernosal
pressure at low doses, and produces vasoconstriction followed by
decrease in pressure at high concentrations (32).
Intracellular mechanisms of penile vasoconstriction
Although elevation of [Ca2+]i is considered as a classical trigger
for force development, smooth muscle contraction can also be
modulated through inhibition of myosin light chain (MLC)
phosphatase (MLCP) by Ca2+-independent mechanisms resulting in
an increased MLC phosphorylation and force at constant [Ca2+]i,
which is referred to as Ca2+ sensitization (33). Vasoconstrictor agonists
binding G-protein-coupled receptors can stimulate both Ca2+
mobilization from intracellular stores and Ca2+ entry through both
dihydropyridine-sensitive L-type and non L-type Ca2+ channels (34).
Whereas in rat and human CC, there is a significant contribution
of Ca2+ from intracellular stores to phenylephrine-induced con-
tractions (35), in penile small arteries, α1-adrenoceptor- and TP
receptor-mediated contractions are largely dependent on Ca2+ entry
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through both voltage-dependent L-type and receptor-operated Ca2+
channels (ROCs), with a minor role for either intracellular Ca2+
mobilization or store-operated Ca2+ (SOC) entry (36, 37). A
capacitative Ca2+ entry through SOCs not coupled to contraction but
probably related to non-contractile functions of vascular smooth
muscle cells, such as protein and gene expression, is also present in
penile small arteries. Despite the large extracellular Ca2+ dependence
of penile vasoconstriction, there are also potent mechanisms of Ca2+
sensitization of the contractile proteins involving several kinases such
as protein kinase C (PKC), tyrosine kinases (TKs) and Rho kinase
(RhoK) (37), which suggests that Ca2+ entry and Ca2+ sensitization
may cooperate to elicit vasoconstriction upon α1-adrenergic receptor
stimulation. Rho A is a member of the Ras superfamily of small
GTP-binding proteins and Rho kinase (RhoK) is a serine-threonine
kinase which is activated by RhoA (33) and has been shown to play
a key role in the physiology of erection. Thus, inhibition of RhoK in
a rat in vivo model markedly increases intracavernosal pressure and
leads to erection (38) and adeno-associated viral gene transfer of
dominant negative RhoA mutant enhances erectile function (39). In
human CC, RhoA-mediated Ca2+ sensitization contributes to smooth
muscle contraction and flaccidity (40). Interestingly, we have recently
shown that RhoK is involved not only in the Ca2+ sensitization of the
contractile apparatus but also in the regulation of Ca2+ entry through
ROC channels upon α1-adrenoceptor activation in rat penile small
arteries (41). These findings suggest that RhoK and other kinases
involved in Ca2+ homeostasis of penile arteries represent potential
therapeutic targets for the treatment of organic ED (Figure 1).
REGULATION OF PENILE VASODILATATION
AND ERECTION
Accumulating experimental evidence for more than a decade now
has supported nitric oxide (NO) as a central component of the major
signal transduction pathway mediating penile erectile responses.
Wheras the role of NO as a neurotransmiter in the reflex arc that
initiates erection was early established, endothelial-derived NO is
becoming increasingly recognized as a key factor in the vascular
homeostasis and physiology of penile erection.
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FIGURE 1. Penile vasoconstriction and flaccidity. Noradrenaline (NA) released
from sympathetic nerves acts on a1 and a2 postsynaptic receptors to elicit
vasoconstrcition and on a2 presynaptic receptors to down regulate its own release
and that of nitric oxide (NO). Activation of a1 adrenoceptors evokes Ca
2+ entry
through voltage.dependent (VOC) and receptor-operated channels (ROC)
regulated by Rho kinase (RhoK), thus activating myosin light chain (MLC) kinase
(MLCK) which phosphorylates MLC. Ca2+ sensitization is also activated
through RhoK, protein kinase C (PKC) and tyrosine kinases (TKs) leading to
phosphorylation of MLC phosphatase (MLCP). Neuropeptide Y (NPY) is coreleased
with NA from sympathetic nerves and acts Y1 and Y2 postsynaptic receptors to
enhance NA contractions and on Y2 receptors to limit NA. Adrenaline (A) can
elicit relaxation through b2 adrenoceptors linked to adenylate cyclase (AC), increa-
se of cAMP and activation of protein kinase A (PKA) to enhance K+ efflux and
decrease intracellular Ca2+ and contraction. AII: angiotensin II; NT: Nerve termi-
nal; SMC: Smooth muscle cell.
Non-adrenergic Non-cholinergic (NANC) NO-containing nerves
Penile erection is initiated by activation of parasympathetic
nerves leading to vasodilatation of cavernous and helicine arteries
and to the relaxation of trabecular smooth muscle. However, classical
physiological studies carried out in several animal species and man
showed that erection induced by activation of pelvic or cavernous
nerves was atropine-resistant (5). The neurotransmitter involved in
the erectile responses was further shown to be NO, and it is now
well established that NO locally released from nerves and
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endothelium is the main chemical mediator of the vasodilatation
and trabecular relaxation involved in penile erection.
The catalytic production of NO requires the enzyme NO synthase,
expressed in many biological tissues as 3 main isoforms: two
constitutive isoforms, neuronal NOS (nNOS) and endothelial NOS
(eNOS), that require Ca2+ and calmodulin for activity, and one
inducible isoform (iNOS), that is Ca2+- and calmodulin- independent
and is expressed in response to inflammatory mediators (42). nNOS
and eNOS are the principal isoforms involved in penile erection and
are present in the nerves and endothelium of the penis, respectively
(43-45). nNOS is present in the pelvic plexus and in terminal
branches of the cavernous nerves innervating the trabecular smooth
muscle and penile vasculature (43, 46). nNOS and vesicular ACh
transporter (VAChT) are co-localized in most nerve terminals
surrounding penile small arteries which suggests that ACh and NO
coexist in the same parasympathetic cholinergic neurons that control
penile arterial tone (44, 45).
Investigations by our group first provided functional evidence for
the involvement of NO in the NANC inhibitory neurotransmission of
penile resistance arteries or helicine arteries. Thus, the NANC
relaxations elicited by electrical field simulation (EFS) were
endothelium-independent, inhibited by the L-arginine analogue, NG-
nitro-L-arginine, by the NO scavenger, oxyhaemoglobin, and by
inhibitors of guanylate cyclase (47, 48). Moreover, exogenous NO
and nitrosothiols mimicked the vasodilatation induced by EFS (22,
47, 48), which suggests that NO or a NO-like substance released
form nitrergic nerves mediates the neurogenic relaxations of penile
resistance arteries.
Until recently, the defined role of nNOS and eNOS in penile
erection has been a subject of debate, specially because erectile
function and mating behaviour are preserved in mice lacking the
genes for eNOS and nNOS (49, 50). Recently, a nNOS gene variant
resulting from alternative mRNA splicing of the βnNOS in exon 1
has been confirmed as a major mediator in penile erection by using
nNOS, eNOS and doubly mutant deficient mice (51).
Concerning the role of other neural mediators released from
parsympathetic nerve terminals during penile erection, the classical
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cholinergic neurotransmitter acetylcholine (ACh) relaxes CC smooth
muscle and penile arteries and veins (5, 22, 24, 52), despite the fact
that erection is atropine-resistant. ACh released from cholinergic
nerves during erection probably has a role decreasing sympathetic
adrenergic tone, though its action on prejunctional muscarinic
receptors at sympathetic nerve terminals as reported in other small
arteries and CC (7, 8, 53).
There is a rich presence of peptidergic nerves containing
Vaoactive Intestinal Peptide (VIP) in the penis and nNOS, VIP and
VAChT are co-localized in the same perivascular nerve terminals
around penile arteries and in trabecular smooth muscle (44, 45). VIP
induces potent relaxations in penile arteries and veins (5, 54).
However, VIP antagonists do not inhibit neurogenic relaxations in
penile small arteries but VIP relaxant responses are partially blocked
by NOS inihibition, which suggests that VIP may have a presynaptic
facilitatory role in the nitregic neurotranmission (54).
The synthesis and release of NO in the penile vasculature is
modulated by several factors such as neurotransmitters, hormones,
autacoids and O2 tension. Noradrenaline from sympathetic nerves
down-regulates NO release through α2-adrenoceptors in penile
resistance arteries (55). The expression and activity of NOS can also
be regulated by protaglandins and PGE1 exerts a long term up-
regulation of NO synthesis by increasing the penile content of both
nNOS and eNOS after repeat treatment (56).
Partial O2 pressure (pO2) in the blood of the CC plays a key role
in the regulation of penile haemodynamics. pO2 values are similar to
those of venous blood during flaccidity and they rise to 90-100 mm
Hg during erection, as a result of the increased arerial inflow to the
sinuses (57). Since molecular O2 is a substrate for NO synthesis,
pO2 regulates the ability of CC smooth muscle to relax in response
to EFS of the nerves and endothelium-dependent vasodilators
such as ACh, these NO-dependent responses being progressively
inhibited as a function decreasing pO2 levels (57). Furthermore, both
nNOS and eNOS proteins dramatically decrease in the erectile tissue
during chronic cavernosal isquemia which suggests that arterial
insufficiency and subsequent exposure of erectile tissue to hypoxia
impairs NOS expression and thus NO synthesis and relaxation (58).
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This probably underlies arteriogenic ED induced by atherosclerosis
and other arterial occlusive diseases.
Local factors regulating penile vasodilatation
Relaxant prostanoids synthesized by both smooth muscle and
endothelial cells, are involved in the maintenance of penile arteriolar
tone (22, 26) and in the endothelium-dependent vasodilatations of
penile arteries in some animal species (54). Since PGE1 is the most
efficacious drug used in the intracavernous therapy of ED, its relaxant
effects are well characterized in both arterial and trabecular smooth
muscle of the penis. Thus, PGE1 evokes endothelium- and NO-
independent relaxations mediated by cAMP in horse penile resistance
arteries (59, 60), this relaxant effect of PGE1 in human arteries being
correlated with its clinical effectiveness when injected intracaver-
nously in patients (61). The vasodilator effects of PGI2 and PGE1 are
mediated by IP and EP (EP2/EP4) receptors coupled to Gs proteins and
to the activation of adenylate cyclase, in human penile arteries (26).
Role of the endothelium in the regulation of penile
vasculature
The endothelium, located at the interphase between blood and
the vascular wall, regulates the underlying vascular smooth muscle
tone by synthesizing short life vasoactive mediators such as NO,
endothelium-derived hyperpolarizing factor (EDHF), prostacyclin
(PGI2), AII and endothelins (ETs) (62).
Endothelial-derived NO is produced in the penis by activation of
eNOS in response to both hemodynamic stimuli like shear stress and
pulsatile stretch generated by increased blood flow, and by
neurohumoral factors such as ACh, bradikynin and histamine acting
on specific endothelial receptors (7, 8, 22, 24, 52). Activation of
eNOS by agonists is induced by increases in intracellular Ca2+
resulting from activation of G-protein-coupled receptors. Ca2+ binds
to calmodulin and this classic mode of eNOS activation by Ca2+/
calmodulin accounts for rapid and transient production of
endothelial NO (63).
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NO is basally released from the arterial endothelium, as shown by
the increase in sponaneous myogenic tone after blockade of NOS in
human and equine penile small arteries (22, 48). The relative contri-
bution of endothelial NO to the agonist-induced vasodilations of the
erectile tissues is variable, being more relevant in CC and large penile
arteries and veins (23, 24, 48) than in the small penile resistance arte-
ries where a non-NO non-prostanoid factor is a major component of
the endothelium-dependent relaxant responses (22, 64, 65).
The physiological contribution of endothelial NO released by
shear-stres to penile vasodilatation has recently been suggested by
cllinical investigations demonstrating a flow-dependent arterial
dilatation, measured by the changes in the cavernous artery diameter
after 5 min occlusion of penile flow (66). These studies showed that
flow-induced vasodilatation is strongly impaired in patients with
organic ED and prosposed this measurement as a clinical test to
evaluate penile endothelial function. However, the involvement of
NO in the flow-dependent dilatation of penile arteries awaits further
confirmation, although recent studies have elucidated the link
between increased blood flow to the penis and eNOS activity, thus
also clarifying the physiological interaction between endothelial and
nerve-derived NO during penile erection. Thus, erection elicited by
cavernosal neve stimulation is mediated by phosphatidylinositol 3-
kinase (PI3-kinase) and activation of the protein kinase Akt. (67).
This pathway phosphorylates eNOS at Ser-1177 thereby increasing
endothelial-derived NO (68) and is responsible for sustained NO
production and the maintenance of maximal erection (67, 69). The
most important physiological agonist for such eNOS activation is
shear stress, although several hormones and growth factors also
increase the activity of PI3-K and endothelial NO production after
phosphorylation of eNOS. This pathway thus explains the role and
interactions nNOS and eNOS during penile erection. Neural NO–
mediated vasodilatation and increased blood flow to the CC produced
by parasympathetic activation during the initiation of erection leads
to shear-stress mediated stimulation of the endothelial lining in
penile arteries, which in turn releases NO from the endothelium and
produces further vasodilatation and sustained erection.
The subcellular location of eNOS, its interaction with the protein
caveolin-1 and the phophorylation state of serine and treonine
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residues of the enzyme play a role in the posttranslational regulation
of eNOS (63, 67, 68).
EDHF
In systemic small arteries including penile resistance arteries,
there is a significant NOS- and cyclooxygenase-resistant relaxation
evoked by endothelium-dependent agonists under conditions of NOS
blockade, in contrast to that observed in CC where the endothelium-
dependent vasodilatation evoked by ACh is blunted by blockade of
NOS (22,48,63). This non-NO non-prostanoid endothelial is
associated with cyclic nucleotide-independent hyperpolarization of
arterial smooth muscle thereby being referred to as «endothelium-
derived hyperpolarizing factor» (EDHF) (62). As reported for the
systemic circulation, in both penile arteries and veins there is also
a correlation between vessel size and the relative contribution of
EDHF to the endothelium-dependent relaxations, the smaller the
vessel the larger the component of the relaxation resistant to NOS
blockade (22, 24, 48, 54).
In horse penile small arteries, we first observed that the
component of the endothelium-dependent relaxations resistant to
NOS- and cyclooxygenase blockade was inhibited by raising
extracellular K+ and by a combination of intermediate- and small-
conductance Ca2+-activated K+ (KCa) channel blockers, thus suggesting
the involvement of a hyperpolarizing factor (22). These findings were
further confirmed in human penile arteries, where the EDHF-
mediated relaxations were enhanced by calcium dobesilate (64). In
horse penile arteries, the EDHF-type response is also markedly
inhibited by ouabain which suggests an involvement of the Na+-K+
ATPase (22). The identity of EDHF still remains controversial and
there is probably more than one EDHF (62, 70). The available
experimental evidence supports three explanations for the identity
and actions of EDHF: a) increased [Ca2+]i triggers the synthesis of a
CP450 metabolite which is essential for the EDHF-type responses, b)
endothelial cell hyperpolarization is transmitted to the smooth
muscle cell through myoendothelial gap-junctions that couple
both types of cells providing a low-resistance electrical pathway; c)
K+ ions released from endothelial cells through KCa induce
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hyperpolarization of the adjacent smooth muscle cells by activating
K+ channels and/or the Na+-K+ ATPase (62, 70). In penile small
arteries, endothelial intermediate-conductance KCa channels have
been shown to be involved in the release of a non-NO non-prostanoid
factor in rat intracavernous arteries (71), although the identity of
EDHF remains to be clarified.
Intracellular signalling pathways underlying penile
vasodilatation
NO constitutively produced and released from nerve terminals
and endothelial cells diffuses into adjacent vascular or trabecular
smooth muscle cells and binds to the enzyme guanylate cyclase to
increase intracellular cGMP levels and the activity of the cGMP-
dependent protein kinase (PKG) (5, 6, 63). The essential role of the
PKG-mediated relaxation in the erectile process has been shown in
PKG-deficient mice that are unable to reproduce and have impaired
relaxations in response to neural- and endothelial-derived NO (72).
Both PKG and the cAMP-dependent kinase PKA can modulate
the activity of K+ channels thereby enhancing K+ efflux and reducing
[Ca2+]i to elicit vasodilatation (73,74). KCa channels are activated by
intracellular Ca2+ and depolarization and they are involved in the
maintenance of resting tone and are downstream mediators of the
NO/cGMP signalling cascade in both CC and penile resistance
arteries (7, 8, 22, 47, 75). Thus, the relaxations induced by NO and
NO donors in horse penile resistance arteries are inhibited by
charybdotoxin and iberiotoxin, and this inhibition is not further
increased by blockers of PKG thus suggesting that the relaxant effect
of NO is due in part to activation of large conductance KCa (BKCa)
through a PKG-dependent mechanism (22, 47, 75). In horse deep
dorsal penile veins, voltage-dependent K+ channels are involved in
the maintenance of basal tone and also in the cGMP-mediated NO-
induced vasodilatation (24).
The NO/cGMP signalling pathway underlying penile erection
involves several targets available for pharmacological intervention in
ED, the most prominent identified thus far being phosphodiesterase
5 (PDE5), the enzyme which enzymatically converts cGMP to its
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inactive form (76). The cGMP-specific cGMP binding PDE5 is the
main cGMP catalyzing enzyme in penile smooth muscle and selective
inhibitors of the enzyme are safe and well tolerated drugs in the oral
therapy of organic ED (76). PDE5 is abundant in the smooth muscle
layer of human penile cavernous and helicine arteries, where the
functional effects of the selective inhibitor sildenafil have been
characterized (77, 78). In contrast to the CC, where sildenafil
produces little or no relaxation but enhances the effects of neural-
released NO (79), sildenafil potently relaxed cavernous and helicine
arteries (54, 77, 78). This vasodilatation was endothelium-dependent
and blocked by inhibitors of NOS, guanlylate cyclase and BKCa
channels which suggests that by inhibiting cGMP break-down
sildenafil augments the relaxing effects of endothelial-derived NO
(75, 78). These observations are consistent with studies showing that
sildenafil cannot normalize the impaired endothelium-dependent
responses of human penile arteries in diabetic patients with ED (65)
and could explain the suboptimal responses to oral PDEs inhibitors
in these patients, in whom endothelial NO availability is decreased
(69).
Several agonists acting on G-protein coupled receptors, such as
β-adrenoceptor agonists, relaxant prostanoids and VIP activate
adenylate cyclase and increase intracellular cAMP levels. In penile
small arteries, PGE1 relaxant reponses are mediated by cAMP and
activation of ATP-sensitive K+ channels (KATP) (59,80), in contrast to
CC where KCa channels are involved (81). The activity of cAMP is
terminated by the cAMP-specific PDE4 and the cGMP-inhibited
cAMP-specific PDE3. They have been localized in the smooth muscle
layer of intracavernous and penile resistance arteries, and in the
case of PDE4 also in the cytoplasm of endothelial cells lining the
cavernous arteries (77). Selective inhbition of PDE4 and PDE3
evoked potent relaxations in penile resistance arteries, which
suggests an enhancement of the effects of basal cAMP production in
the arterial wall; the fact that relaxations evoked by the selective
PDE4 inhibitor rolipram are inhibited by cycloxygenase blockade in
turn indicates an involvement of PDE4 in the release and/or effects
of relaxant prostanoids (59) (Figure 2).
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FIGURE 2. Penile vasodilatation and erection. Nitric oxide (NO) is released
from parasympathetic nerve terminals and difusses into adjacent smooth muscle
to activate guanylate cyclse (GC). Increased cGMP levels activate protein kinase G
(PKG) which can either stimulate Ca2+-activated K+ channels (KCa) and reduce
intracellular Ca2+, or phosphorylate myosin light chain phosphatase (MLCP) and
reduce Ca2+ sensitivity. PKG can phosphorylate Rho kinase (RhoK) and thus
reduce its activity. Relaxation induced by neural NO increases blood flow and
shear stress on the endothelial cells thereby increasing Akt phophorylation of
eNOS and NO production, and also releasing prostanoids and endothelium-derived
hyperpolarizing factor (EDHF). Nerve-derived acetylcholine (ACh) can either limit
noradrenaline (NA) release from sympathetic nerves through M2 receptors or
stimulate endothelial M3 receptors to induce NO, EDHF and prostanoids release.
Prostanoids activate IP/EP receptors coupled to adenylate cyclase (AC) and increa-
sed cAMP activate protein kinase A (PKA). COX: Cyclooxygenase; CP450: Cyto-
chrome P 450; EC: Endothelial cell.; NT: Nerve terminal; PDE: Phosphodiesterase;
PGI2: Prostacyclin; PLC: Phospholipase C; SMC: Smooth muscle cell.
ENDOTHELIAL DYSFUNCTION AND ERECTILE
DYSFUNCTION
The high prevalence of ED in patients with cardiovascular
disorders such as aging, hypercholesterolemia and hypertension, in
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which there is endothelial dysfunction and reduced NO bioavai-
lability (2-4), suggests the essential role of the vascular endothelium
in the physiology of penile erection, as well as its importance in the
pathogenesis of ED.
Mechanisms that may be related to the endothelial dysfunction
and to the loss of NO bioavailability during vasculogenic ED include
decreased eNOS expression and activity, dysregulation of eNOS
phosphorylation, increased NO scavenging by reactive O2 species
(ROS), eNOS uncoupling, decreased levels of eNOS cofactors and
substrate and increased interaction with contractile signalling
pathways (63). Decreased erectile responses associated with impaired
endothelium-dependent vasodilation and eNOS expression/activity in
CC have been demonstrated in experimental animal models of
diabetes, hypercholesterolemia and hypertension (63, 82-84).
However, little is known about the impaired function of the penile
vasculature and recent evidence suggests that arterial insufficiency
precedes the structural and functional changes in CC leading to ED.
On the other hand, whereas in CC there is a functional impairment
of the NO-mediated endothelium-dependent responses during
vasculogenic ED (82-84), endothelial abnormalities also include
reduced EDHF-type relaxations in penile small arteries from diabetic
men and from a rat model of renal hypertension (65, 85). These
observations suggest the need to investigate the altered functional
responses associated to cardiovascular risk situations leading to ED
in penile arteries and veins.
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